Physician
Kids Rule Pediatrics, PA
Kids Rule Pediatrics, PA was paid $3.70M by Medicaid between Dec 2018 and Dec 2024, across 58 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 26% of everything it billed.
33Billing provider infoKIDS RULE PEDIATRICS, PA
MOREHEAD CITY, NC 28557
MOREHEAD CITY, NC 28557
33aNPI1720557002assigned 11/16/2018
33bProvider typePediatrics Physician
28Total paid$3.70M
24GClaims167,133
24DCodes billed58
24AFirst – last monthDec 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in North Carolina
Rank by total paid#107 of 433
Median peer was paid$942K
This provider vs. median3.9×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 477 | $17K | |
| 2019 | 11,501 | $463K | |
| 2020 | 10,690 | $432K | |
| 2021 | 24,373 | $608K | |
| 2022 | 40,476 | $853K | |
| 2023 | 40,499 | $753K | |
| 2024incomplete | 39,117 | $574K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 26% | 11,195 | 9,144 | $947K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 16% | 10,071 | 8,455 | $580K |
| 99199 | Unlisted special service, procedure or report | 13% | 86,727 | 51,723 | $496K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 8.1% | 2,395 | 2,015 | $299K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 7.6% | 2,289 | 1,756 | $280K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 3.5% | 1,641 | 1,431 | $131K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 3.4% | 1,447 | 1,265 | $124K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 2.7% | 5,426 | 4,672 | $100K |
| 99417 | Prolong home eval add 15m | 2.5% | 545 | 452 | $91K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 2.5% | 3,395 | 2,770 | $91K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 2.1% | 2,513 | 2,160 | $77K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 2.1% | 1,003 | 824 | $76K |
46 more codes
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.0% | 1,652 | $76K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2.0% | 2,217 | $75K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1.4% | 6,172 | $52K |
| D0145 | Oral evaluation for a patient under three years of age | 1.2% | 1,338 | $44K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.0% | 407 | $38K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 511 | $26K |
| 96127 | <1% | 3,824 | $19K | |
| D1206 | Topical application of fluoride varnish | <1% | 1,250 | $19K |
| 99401 | <1% | 1,015 | $15K | |
| 85018 | <1% | 3,797 | $6K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 431 | $6K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 396 | $5K |
| 99354 | <1% | 30 | $4K | |
| 90473 | <1% | 141 | $3K | |
| 87634 | <1% | 99 | $3K | |
| 90474 | <1% | 149 | $3K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 121 | $2K |
| 96160 | <1% | 532 | $2K | |
| 90686 | <1% | 1,079 | $1K | |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 17 | $1K |
| 0071A | <1% | 26 | $1K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 90 | $1K |
| 92551 | <1% | 5,154 | $1K | |
| 96161 | <1% | 349 | $1K | |
| 99460 | <1% | 13 | $1K | |
| 0072A | <1% | 13 | $881.72 | |
| 90672 | <1% | 316 | $737.52 | |
| 99173 | <1% | 5,210 | $662.01 | |
| 90619 | <1% | 15 | $152.40 | |
| 81002 | <1% | 14 | $36.41 | |
| 90674 | <1% | 88 | $30.00 | |
| 94760 | <1% | 135 | $19.43 | |
| 90661 | <1% | 40 | $0.02 | |
| 90685 | 0% | 12 | $0.00 | |
| 90670 | 0% | 419 | $0.00 | |
| 3280F | 0% | 29 | $0.00 | |
| 90633 | 0% | 27 | $0.00 | |
| 99072 | 0% | 35 | $0.00 | |
| 2000F | 0% | 475 | $0.00 | |
| 3008F | 0% | 510 | $0.00 | |
| 90723 | 0% | 91 | $0.00 | |
| 90647 | 0% | 90 | $0.00 | |
| 90680 | 0% | 54 | $0.00 | |
| 91307 | 0% | 39 | $0.00 | |
| 90677 | 0% | 45 | $0.00 | |
| 99000 | 0% | 19 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSALTER, KARLYN (OFFICE MANAGER)